Seneca Biopharmaceuticals, Inc. (SNCA)

- senecabio.com

Clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences and technologies that will provide meaningful therapies for patients.

494,196 $ 8,280.00


Seneca Biopharmaceuticals, Inc. (SNCA)

- investor.neuralstem.com

Clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences and technologies that will provide meaningful therapies for patients.

1,422,643 $ 960.00